Abstract:Objective During primary total knee arthroplasty(TKA),anticoagulant drugs are used for prevention of major venous thrombosis of lower limbs,and this often leads to the increase of perioperative blood loss.To retrospectively analyse the impact of low molecular weight heparin on hidden blood loss and transfusion rate after primary TKA by comparing with the use of aspirin.Methods Between October 2007 and August 2009,the clinical data from 286 patients undergoing primary TKA surgery were retrospectively analyzed.In accordance with different anticoagulation methods,the cases were divided into 2 groups,the trial group(n=166) and the control group(n=120).In the trial group,the patients received low molecular weight heparin(4 000-6 000 U/day) from 8-12 hours after TKA for 14 days;there were 27 males and 139 females with an average age of 66.1 years(range,22-82 years);the body mass index(BMI) was 26.79 ± 3.87;and the locations were the left knee in 99 cases and the right knee in 67 cases with an average disease duration of 4.1 years(range,1.8-8.6 years).In the control group,the patients received aspirin(150 mg/day) for 14 days;there were 21 males and 99 females with an average age of 64.9 years(range,40-84 years);the BMI was 27.87 ± 3.62;and the locations were the left knee in 78 cases and the right knee in 42 cases with an average disease duration of 4.9 years(range,1.5-8.2 years).There was no significant difference in the general data between 2 groups(P > 0.05).Results The incisions healed by first intention in all patients.Postoperative deep venous thrombosis occurred in 37 patients of the trial group and in 28 cases of the control group.All the patients were followed up 12-34 months(mean,21.6 months).There were signif icant differences in the United States Hospital for Special Surgery(HSS) score of 2 groups between before surgery and after surgery(P < 0.05).The hidden blood loss was(40.55 ± 37.75) g/L in the trial group and(32.52 ± 40.13) g/L in the control group,showing signif icant difference(t=3.387,P=0.001);the dominant blood loss was(24.08 ± 14.63) g/L and(27.91 ± 18.47) g/L respectively,showing no significant difference(t= —1.899,P=0.059).The blood transfusion rates were 40.4%(67/166) in the trial group and 30.0%(36/120) in the control group,showing no signif icant difference(χ2=2.771,P=0.081);the transfusion volumes were(1.44 ± 4.03) U and(0.97 ± 3.50) U respectively,showing signif icant difference(t=2.071,P=0.039).Conclusion The low molecular weight heparin has effect on the hidden blood loss after primary TKA,which may increase postoperative blood loss and blood transfusion rate.The changes in hemoglobin should be monitored during the anticoagulant therapy,and the blood volume should be added promptly.

Prophylaxis of LMWH for deep venous thrombotic after total knee arthroplasty in Asian patients: Meta-analysis

Low Molecular Weight Heparin for the Prevention of Deep Venous Thrombosis after Total Knee Arthroplasty: A Systematic Review and Meta-Analysis

Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: A meta-analysis

[Low-Molecular-weight Heparin for Preventing Deep-Vein Thrombosis after Total Joint Arthroplasty].

Low-molecular-weight heparin followed by rivaroxaban or not for the prevention of deep venous thromboembolism after total knee arthroplasty.

Low Molecular Weight Heparin Versus Other Anti-Thrombotic Agents for Prevention of Venous Thromboembolic Events after Total Hip or Total Knee Replacement Surgery: a Systematic Review and Meta-Analysis

Efficacy and Safety of the Low Molecular Weight Heparin and Mailuoshutong to Prevent Deep Venous Thrombosis

Administering Aspirin, Rivaroxaban and Low-Molecular-weight Heparin to Prevent Deep Venous Thrombosis after Total Knee Arthroplasty

Deep Venous Thrombosis after Knee Arthroscopy: A Systematic Review and Meta-Analysis

Thromboprophylactic Efficacy and Safety of Anticoagulants After Arthroscopic Knee Surgery: A Systematic Review and Meta-Analysis

The Incidence of Symptomatic In-Hospital VTEs in Asian Patients Undergoing Joint Arthroplasty Was Low: a Prospective, Multicenter, 17,660-Patient-enrolled Cohort Study

State-of-the-Art Evidence-Based Review of Aspirin for Thromboprophylaxis in Modern Elective Total Hip and Kneearthroplasty

Curative effect of rivaroxaban versus low molecular weight heparin to prevent deep venous thrombosis following total hip arthroplasty

Incidence of Venous Thromboembolism after Primary Total Hip Arthroplasty with Mechanical Prophylaxis in Hong Kong Chinese

Prophylactic efficacy of two anticoagulant drug heparin calcium and rivaroxaban, on venous thrombosis after knee arthroplasty

IMPACT OF LOW MOLECULAR WEIGHT HEPARIN ON HIDDEN BLOOD LOSS AND BLOOD TRANSFUSION RATE AFTER PRIMARY TOTAL KNEE ARTHROPLASTY

Effect of Rivaroxaban verses Low Molecular Weight Heparin on Preventing Deep Vein Thrombosis in Postoperative Hip or Knee Arthroplasty

Pharmacotherapy for Venous Thromboprophylaxis following Total Hip or Knee Arthroplasty: A Systematic Review and Network Meta-analysis

Efficacy of Panax Notoginseng for Deep Venous Thrombosis in Total Hip Arthroplasty and Total Knee Arthroplasty: a Meta-analysis

Clinical Risk Factors for Deep Vein Thrombosis after Total Hip and Knee Arthroplasty

Aspirin versus low-molecular-weight heparin for thromboprophylaxis after orthopaedic surgery: a systematic review and meta-analysis